Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide
AssigneeSanten Phamaceutical Co., Ltd.
InventorsAsuka Sakamoto, Masatsugu Nakamura
Life of this patent
Estimating the term…
Abstract
A combination of hyaluronic acid or a salt thereof and flavin adenine dinucleotide or a salt thereof can be an inhibitor for corneal epithelial cell death induced by ultraviolet irradiation and/or dryness because it significantly inhibits the decline of the number of living cells in corneal epithelial cells induced by ultraviolet irradiation or dryness.
Claims15
An inhibitor for corneal epithelial cell death characterized by combining hyaluronic acid or a salt thereof and flavin adenine dinucleotide or a salt thereof, the corneal epithelial cell death being induced by ultraviolet irradiation and/or dryness.
An inhibitor for corneal epithelial cell death characterized by combining hyaluronic acid or a salt thereof and flavin adenine dinucleotide or a salt thereof, the corneal epithelial cell death being induced by ultraviolet B wave irradiation.
A method for inhibiting corneal epithelial cell death comprising administering a combination of pharmaceutically effective amounts of hyaluronic acid or a salt thereof and flavin adenine dinucleotide or a salt thereof to a patient, the corneal epithelial cell death being induced by ultraviolet irradiation and/or dryness.
A method for inhibiting corneal epithelial cell death comprising administering a combination of pharmaceutically effective amounts of hyaluronic acid or a salt thereof and flavin adenine dinucleotide or a salt thereof to a patient, the corneal epithelial cell death being induced by ultraviolet B wave irradiation.
15-28. (canceled)
Dependencies are inferred from the claim text.